Speaker Profile

___	__
	Biography Dr. Popadiuk is Associate Professor Dept. Obstetrics and Gynecology, Faculty of Medicine at Memorial University. She has been a practicing Gynecologic Oncologist since 1998 with special interest in Cervical Cancer. She completed her residency in Obstetrics and Gynecology at McGill University followed by Gynecologic Oncology training at the University of Toronto. She has been the Medical Director for the Cervical Screening Initiatives Programme in Newfoundland and Labrador since 2003. She is Lead for the Canadian Partnership Against Cancer Oncosim HPV Cervical Microsimulation Oncosim Model which assesses the effects of various screening and preventive strategies on cervical cancer outcomes in Canada. She has been on the board and executive of APOG and SOGC and is chair of the CFWH. Disclosure 1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Popadiuk is Associate Professor Dept. Obstetrics and Gynecology, Faculty of Medicine at Memorial University. She has been a practicing Gynecologic Oncologist since 1998 with special interest in Cervical Cancer. She completed her residency in Obstetrics and Gynecology at McGill University followed by Gynecologic Oncology training at the University of Toronto. She has been the Medical Director for the Cervical Screening Initiatives Programme in Newfoundland and Labrador since 2003. She is Lead for the Canadian Partnership Against Cancer Oncosim HPV Cervical Microsimulation Oncosim Model which assesses the effects of various screening and preventive strategies on cervical cancer outcomes in Canada. She has been on the board and executive of APOG and SOGC and is chair of the CFWH.
Disclosure
1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).